Lemborexant Synthesis Route for High Yield and Low Impurities

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for producing Lemborexant, a potent orexin receptor antagonist, face challenges such as low yield, the need to account for residual enzymes during industrial production, and the presence of impurities like compounds of Formula VI, Formula IX, Formula X, Formula XII, Formula XIII, Formula XIV, and Formula XV.

Innovation Solution

A synthesis method involving specific chemical reactions and conditions is developed to produce Lemborexant, including steps like adding a Grignard reagent to a mixture of compounds in solvents, reacting with oxidants, and using sodium hypochlorite and sodium chlorite, to achieve high purity with minimal impurities.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If the method in Patent Literature 1 is used to produce Lemborexant, then the synthesis can be completed, but the yield is low

Engineering Contradiction:
ImproveyieldVSAvoidmanufacturability
Core Design Contradiction:
ProductivityVSEase of manufacture

Solution Approach 1:

The synthesis route is divided into distinct segments with optimized reaction conditions. The patent introduces intermediate compounds (Formula VI, Formula IX, Formula X, Formula XII, Formula XIII, Formula XIV, Formula XV) that break down the synthesis into manageable steps, each with controlled parameters to maximize yield while maintaining ease of manufacture.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent optimizes reaction parameters including temperature, solvent composition (toluene and tetrahydrofuran), and reagent ratios to improve yield. Specific conditions such as adding Grignard reagent at controlled temperatures and using specific solvent ratios are employed to enhance productivity without complicating the manufacturing process.

Inventive Principle:
Principle #35Parameter changes

2Productivity

If the method in Patent Literature 2 is used to produce Lemborexant, then the synthesis can be completed, but residual enzymes must be accounted for during industrial production

Engineering Contradiction:
ImproveyieldVSAvoidpurity
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent eliminates enzymatic steps from the synthesis route, removing the source of residual enzyme contamination. The chemical synthesis method using Grignard reagents and oxidants replaces biological catalysis, ensuring no enzyme residues remain in the final product while maintaining high productivity.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent uses readily available chemical reagents and standard laboratory equipment instead of expensive enzyme systems. The chemical reagents are stable, easy to handle, and leave no persistent residues, making the process more reliable for industrial production.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Productivity

If conventional synthesis methods are used, then Lemborexant can be produced, but impurities such as compounds of Formula VI, Formula IX, Formula X, Formula XII, Formula XIII, Formula XIV, and Formula XV are present

Engineering Contradiction:
ImproveyieldVSAvoidpurity
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent employs preliminary purification steps and selective reaction conditions to prevent impurity formation before they become problematic. By controlling the sequence of reactions and using specific reagents, the method minimizes the formation of unwanted byproducts while maintaining high yield.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent converts potential impurities into useful intermediates or eliminates them through selective oxidation and purification steps. The oxidants used in the synthesis selectively transform unwanted byproducts into desired compounds or easily removable substances, turning potential contaminants into benefits.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method results in Lemborexant with a high yield and a small amount of impurities, suitable for industrial production and pharmaceutical use as an orexin-2 receptor antagonist.

Implementation Method 1

adding a Grignard reagent to a mixture comprising a compound of Formula II: toluene and tetrahydrofuran

Methodology Applied
Scientific EffectGrignard reaction: Chemical Bonding

Implementation Method 2

reacting with oxidants, and using sodium hypochlorite and sodium chlorite

Methodology Applied
Scientific EffectOxidation: Oxidation

Data Source

PatentUS12479819B2Method and compound useful in preparation of orexin-2 receptor antagonist, and lemborexant having few impurities
Publication Date: 2025.11.25 EISAI R&D MANAGEMENT CO LTD
  • US12479819B2 patent drawing
  • US12479819B2 patent drawing
  • US12479819B2 patent drawing

AI summary

The present application discloses a method and a compound that are useful for preparation of a compound of Formula (XI). Furthermore, the present application discloses the compound of Formula (XI) comprising a small amount of impurities.